Pacer Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.14M | Sell |
34,025
-948,754
| -97% | -$66.1M | 0.01% | 899 |
|
|
2025
Q4 | $65.2M | Buy |
982,779
+922,650
| +1,534% | +$59.6M | 0.17% | 135 |
|
|
2025
Q3 | $4.05M | Sell |
60,129
-1,994
| -3% | -$158K | 0.01% | 771 |
|
|
2025
Q2 | $5.42M | Buy |
62,123
+22,736
| +58% | +$1.78M | 0.01% | 657 |
|
|
2025
Q1 | $2.69M | Sell |
39,387
-11,767
| -23% | -$960K | 0.01% | 855 |
|
|
2024
Q4 | $3.98M | Sell |
51,154
-2,378
| -4% | -$176K | 0.01% | 707 |
|
|
2024
Q3 | $3.59M | Buy |
53,532
+4,213
| +9% | +$346K | 0.01% | 751 |
|
|
2024
Q2 | $5.59M | Buy |
49,319
+4,831
| +11% | +$611K | 0.01% | 559 |
|
|
2024
Q1 | $6.17M | Sell |
44,488
-10,686
| -19% | -$1.34M | 0.01% | 534 |
|
|
2023
Q4 | $6.85M | Buy |
55,174
+4,056
| +8% | +$414K | 0.02% | 497 |
|
|
2023
Q3 | $4.77M | Sell |
51,118
-40,258
| -44% | -$4.54M | 0.02% | 477 |
|
|
2023
Q2 | $11.7M | Sell |
91,376
-42,275
| -32% | -$5.11M | 0.05% | 339 |
|
|
2023
Q1 | $15.5M | Buy |
133,651
+121,179
| +972% | +$13.6M | 0.07% | 288 |
|
|
2022
Q4 | $1.41M | Sell |
12,472
-126,637
| -91% | -$13.9M | 0.01% | 674 |
|
|
2022
Q3 | $11.2M | Buy |
139,109
+119,636
| +614% | +$10.1M | 0.08% | 206 |
|
|
2022
Q2 | $1.45M | Sell |
19,473
-56,311
| -74% | -$5.14M | 0.01% | 479 |
|
|
2022
Q1 | $9.69M | Buy |
75,784
+34,004
| +81% | +$3.72M | 0.08% | 250 |
|
|
2021
Q4 | $5.61M | Buy |
41,780
+4,584
| +12% | +$659K | 0.06% | 299 |
|
|
2021
Q3 | $5.08M | Sell |
37,196
-1,056
| -3% | -$133K | 0.06% | 375 |
|
|
2021
Q2 | $4.08M | Buy |
38,252
+4,488
| +13% | +$431K | 0.06% | 413 |
|
|
2021
Q1 | $3.03M | Sell |
33,764
-1,800
| -5% | -$169K | 0.05% | 401 |
|
|
2020
Q4 | $3.29M | Sell |
35,564
-21,932
| -38% | -$1.96M | 0.06% | 309 |
|
|
2020
Q3 | $5.92M | Sell |
57,496
-3,844
| -6% | -$402K | 0.13% | 129 |
|
|
2020
Q2 | $6.22M | Buy |
+61,340
| New | +$5.49M | 0.13% | 127 |
|
|
2017
Q4 | – | Sell |
-49,588
| Closed | -$607K | – | 1208 |
|
|
2017
Q3 | $607K | Buy |
49,588
+6,752
| +16% | +$119K | 0.05% | 563 |
|
|
2017
Q2 | $783K | Buy |
42,836
+4,340
| +11% | +$80.2K | 0.08% | 356 |
|
|
2017
Q1 | $815K | Buy |
38,496
+6,036
| +19% | +$118K | 0.1% | 252 |
|
|
2016
Q4 | $485K | Sell |
32,460
-2,020
| -6% | -$35.8K | 0.07% | 419 |
|
|
2016
Q3 | $756K | Buy |
34,480
+1,400
| +4% | +$31.2K | 0.11% | 179 |
|
|
2016
Q2 | $656K | Buy |
33,080
+27,672
| +512% | +$471K | 0.1% | 216 |
|
|
2016
Q1 | $92K | Sell |
5,408
-36
| -0.7% | -$601 | 0.02% | 636 |
|
|
2015
Q4 | $111K | Buy |
+5,444
| New | +$113K | 0.03% | 552 |
|
Other funds holding DXCM
VCM
VPM
Pacer Advisors's DXCM Position: Q1 2026 in Review
Pacer Advisors reduced its DexCom (DXCM) stake by 97% in Q1 2026, selling an estimated $66.1M and leaving 34,025 shares worth $2.14M. The position accounts for 0.01% of the portfolio, ranked #899.
Pacer Advisors first reported a position in DXCM in Q4 2015 and has held it in 32 quarters since. The position peaked at $65.2M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Pacer Advisors held 34,025 shares of DexCom worth $2.14M as of Q1 2026.
- Pacer Advisors sold 948,754 DexCom shares in Q1 2026, an estimated $66.1M.
- DexCom made up 0.01% of Pacer Advisors's portfolio in Q1 2026, its #899 holding.
- Pacer Advisors first reported a position in DexCom in Q4 2015 and has held it in 32 quarters since.
- Pacer Advisors's DexCom position peaked at $65.2M in Q4 2025.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.